A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

Clinical trial NCT06215716 · RECRUITING

Trial details

NCT number: NCT06215716
Sponsor: Akero Therapeutics, Inc
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

NASH With Fibrosis MASH With Fibrosis

Start date: 2023-12-01
Primary completion: 2033-02-01
Enrollment: 1650

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.